Search Results

There are 8189947 results for: content related to: Commentary: the link between community-acquired pneumonia and PPI use

  1. Influence of fourth generation poly(propyleneimine) dendrimers on blood cells

    Journal of Biomedical Materials Research Part A

    Volume 100A, Issue 11, November 2012, Pages: 2870–2880, Barbara Ziemba, Inessa Halets, Dzmitry Shcharbin, Dietmar Appelhans, Brigitte Voit, Ireneusz Pieszynski, Maria Bryszewska and Barbara Klajnert

    Version of Record online : 24 MAY 2012, DOI: 10.1002/jbm.a.34222

  2. Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 391–400, Konstantina Sargenti, Hanne Prytz, Anna Strand, Emma Nilsson and Evangelos Kalaitzakis

    Version of Record online : 21 JUL 2014, DOI: 10.1111/liv.12625

  3. You have free access to this content
    Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 6, September 2014, Pages: 695–704, Y. W. Min, K. S. Lim, B.-H. Min, G.-Y. Gwak, Y. H. Paik, M. S. Choi, J. H. Lee, J. J. Kim, K. C. Koh, S. W. Paik, B. C. Yoo and P.-L. Rhee

    Version of Record online : 30 JUL 2014, DOI: 10.1111/apt.12875

  4. Proton pump inhibitors prescribing following the introduction of generic drugs

    European Journal of Clinical Investigation

    Volume 42, Issue 10, October 2012, Pages: 1068–1078, Simona Cammarota, Dario Bruzzese, Giovanni Sarnelli, Anna Citarella, Enrica Menditto, Salvatore Riegler, Ivana G. Savino, Letizia Vozzella, Gaetano Piccinocchi, Luigi Napoli, Giovanni Arpino and Rosario Cuomo

    Version of Record online : 9 JUN 2012, DOI: 10.1111/j.1365-2362.2012.02696.x

  5. You have free access to this content
    Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 11, June 2010, Pages: 1165–1177, J. JOHNSTONE, K. NERENBERG and M. LOEB

    Version of Record online : 4 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04284.x

  6. You have free access to this content
    Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care

    International Journal of Clinical Practice

    Volume 66, Issue 8, August 2012, Pages: 767–773, D. Ahrens, G. Behrens, W. Himmel, M. M. Kochen and J.-F. Chenot

    Version of Record online : 16 JUL 2012, DOI: 10.1111/j.1742-1241.2012.02973.x

  7. Uses of proton pump inhibitors and serum potassium levels

    Pharmacoepidemiology and Drug Safety

    Volume 18, Issue 9, September 2009, Pages: 865–871, Jen-Tzer Gau, Victor Heh, Utkarsh Acharya, Yu-Xiao Yang and Tzu-Cheg Kao

    Version of Record online : 25 JUN 2009, DOI: 10.1002/pds.1795

  8. Activation Effect of Fullerene C60 on the Carbon Dioxide Absorption Performance of Amine-Rich Polypropylenimine Dendrimers


    Volume 8, Issue 16, August 24, 2015, Pages: 2635–2644, Dr. Enrico Andreoli  and Prof. Andrew R. Barron 

    Version of Record online : 24 JUL 2015, DOI: 10.1002/cssc.201500605

  9. Proton pump inhibitors utilisation in older people in New Zealand from 2005 to 2013

    Internal Medicine Journal

    Volume 45, Issue 6, June 2015, Pages: 624–629, P. S. Nishtala and L. Soo

    Version of Record online : 8 JUN 2015, DOI: 10.1111/imj.12757

  10. Factors associated with the initiation of proton pump inhibitors in corticosteroid users

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 366–374, Jeffrey C. Munson, Peter M. Wahl, Gregory Daniel, Stephen E. Kimmel and Sean Hennessy

    Version of Record online : 25 JAN 2012, DOI: 10.1002/pds.2350

  11. You have free access to this content
    Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 11, June 2015, Pages: 1162–1174, S. E. Attwood, C. Ell, J. P. Galmiche, R. Fiocca, J. G. Hatlebakk, B. Hasselgren, G. Långström, M. Jahreskog, S. Eklund, T. Lind and L. Lundell

    Version of Record online : 10 APR 2015, DOI: 10.1111/apt.13194

  12. Oesophageal narrowing on barium oesophagram is more common in adult patients with eosinophilic oesophagitis than PPI-responsive oesophageal eosinophilia

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 11, June 2016, Pages: 1168–1177, A. Podboy, D. A. Katzka, F. Enders, J. J. Larson, D. Geno, L. Kryzer and J. Alexander

    Version of Record online : 30 MAR 2016, DOI: 10.1111/apt.13601

  13. Potato protein isolate-based biopolymers

    Journal of Applied Polymer Science

    Volume 132, Issue 44, November 20, 2015, Yicheng Du, Fangping Chen, Yachuan Zhang, Curtis Rempel, Michael R. Thompson and Qiang Liu

    Version of Record online : 29 JUL 2015, DOI: 10.1002/app.42723

  14. The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 5, September 2016, Pages: 522–530, E. V. Savarino, S. Tolone, O. Bartolo, C. de Cassan, R. Caccaro, F. Galeazzi, L. Nicoletti, R. Salvador, M. Martinato, M. Costantini and V. Savarino

    Version of Record online : 4 JUL 2016, DOI: 10.1111/apt.13718

  15. Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study


    Volume 64, Issue 6, December 2016, Pages: 1893–1899, Elliot B. Tapper, Bruce R. Bacon, Michael P. Curry, Douglas T. Dieterich, Steven L. Flamm, Lauren E. Guest, Kris V. Kowdley, Yoori Lee, Naoky C. Tsai, Zobair M. Younossi and Nezam H. Afdhal

    Version of Record online : 5 OCT 2016, DOI: 10.1002/hep.28782

  16. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1043–1049, Fei-Yuan Hsiao, C. Daniel Mullins, Yu-Wen Wen, Weng-Foung Huang, Pei-Fen Chen and Yi-Wen Tsai

    Version of Record online : 8 AUG 2011, DOI: 10.1002/pds.2202

  17. You have free access to this content
    Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 11, June 2013, Pages: 1103–1111, C. Jacobs, E. Coss Adame, A. Attaluri, J. Valestin and S. S. C. Rao

    Version of Record online : 10 APR 2013, DOI: 10.1111/apt.12304

  18. Gastroesophageal Reflux Disease Treatment

    Practical Manual of Gastroesophageal Reflux Disease

    Marcelo F. Vela, Joel E. Richter, John E. Pandolfino, Pages: 69–82, 2013

    Published Online : 25 JAN 2013, DOI: 10.1002/9781118444788.ch5

  19. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting:

    Catheterization and Cardiovascular Interventions

    Volume 80, Issue 4, 1 October 2012, Pages: 556–563, Hideaki Aihara, Akira Sato, Noriyuki Takeyasu, Hidetaka Nishina, Tomoya Hoshi, Daiki Akiyama, Yuki Kakefuda, Hiroaki Watabe, Kazutaka Aonuma and for the ICAS Registry Investigators

    Version of Record online : 10 JAN 2012, DOI: 10.1002/ccd.23327

  20. Evaluation of PPI

    Patient and Public Involvement Toolkit

    Julia Cartwright, Sally Crowe, Carl Heneghan, Rafael Perera, Douglas Badenoch, Pages: 78–84, 2011

    Published Online : 4 FEB 2011, DOI: 10.1002/9781444328370.ch5